WALNUT CAP (00905) announced its interim results, reporting a net loss of HK$44.125 million, an increase of 64.97% year-on-year.
Walnut Capital (00905) announced its interim results for 2026, with revenue of 150,000 Hong Kong dollars, a decrease of 84.38% year-on-year; a net loss of 44.125 million Hong Kong dollars, an increase of 64.97% year-on-year; and a loss per share of 4.2 Hong Kong cents.
WALNUT CAP (00905) announced its mid-year results for 2026, reporting revenue of HKD 150,000, a year-on-year decrease of 84.38%; a net loss of HKD 44.125 million, a year-on-year increase of 64.97%; and a loss per share of HKD 0.042.
The announcement stated that the increase in losses was primarily due to: (i) an increase of HKD 10.2 million in losses from the sale of cryptocurrencies; (ii) an increase of HKD 8.4 million in net losses resulting from fair value changes of financial assets recorded at fair value through profit or loss; and (iii) a decrease of HKD 800,000 in cryptocurrency interest income, which was partially offset by a reduction of HKD 2.1 million in administrative and other operational expenses.
Related Articles

US Stock Market Move | Estee Lauder Companies Inc. Class A (EL.US) surged over 17% as its fourth fiscal quarter results exceeded expectations.

Jiangsu Hengrui Pharmaceuticals (01276) recommends adopting the 2026 A-share employee stock ownership plan.

AMASSE CAPITAL (08168): Deng Yaoji and Song Kunxiang have been appointed as independent non-executive directors.
US Stock Market Move | Estee Lauder Companies Inc. Class A (EL.US) surged over 17% as its fourth fiscal quarter results exceeded expectations.

Jiangsu Hengrui Pharmaceuticals (01276) recommends adopting the 2026 A-share employee stock ownership plan.

AMASSE CAPITAL (08168): Deng Yaoji and Song Kunxiang have been appointed as independent non-executive directors.

RECOMMEND





